About 50 results
Open links in new tab
  1. Medscape

    Loading Profile...

  2. Medscape

    Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our …

  3. Latest Medical News, Clinical Trials, Guidelines - Medscape

    Jan 12, 2026 · Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.

  4. Serum Haptoglobin: A Prognostic Biomarker for Urticaria?

    Jan 14, 2026 · Levels of haptoglobin in serum may help predict which patients with chronic spontaneous urticaria will achieve complete disease control.

  5. Preventing Shoulder Pain After Cardiac Device Implantation - Page 2

    Although there were different implanting physicians, the technique was standardized such that only the subcutaneous approach in the subclavicular region with an incision located medial to and ...

  6. Do Food Allergies Affect Growth Patterns in Children? - Medscape

    Jan 13, 2026 · Children with food allergies may have higher-than-expected rates of short stature and low weight, a Dutch study finds.

  7. Quick Take: Hypoxic Respiratory Failure - Medscape

    Jan 16, 2026 · Dr Neena Chandrasekaran discusses hypoxic respiratory failure. This can happen due to many causes. The most common is a ventilation-perfusion mismatch that can happen in terms of …

  8. News Quiz: Top Pediatrics Stories From 2015 - Page 6 - Medscape

    Dec 22, 2015 · FDA Okays Once-Daily Dyanavel XR for ADHD in Children In October, the FDA approved the amphetamine Dyanavel XR (Tris Pharma Inc), a once-daily extended-release oral …

  9. NICE Recommends Age-Based CA125 Testing for Ovarian Cancer

    Jan 6, 2026 · NICE has proposed age-based CA125 thresholds to improve early ovarian cancer detection while reducing unnecessary scans in younger women.

  10. A New Weight Loss Drug With No Side Effects? Yes…So Far

    Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side effects — especially muscle loss.